[기자가 간다] Life Semantics, KOSDAQ’Knock’ with non-face-to-face healthcare

Lifesemantics, a digital therapeutic company, enters the KOSDAQ market. Amid the growing demand for non-face-to-face medical treatment due to the novel coronavirus infection (Corona 19), the government is also taking a drive to revitalize the market, raising expectations for the growth of life semantics.

Life Semantics is aspiring to become a leading global digital health company by spurring the development of digital therapeutics and promoting clinical trials in the US FDA.

◆ Establish a full lineup of’digital health’ business

According to the financial investment industry on the 4th, Life Semantics will enter the KOSDAQ market at the end of March.

Established in 2012, Life Semantics is a leading digital health platform company that utilizes medical information technology and artificial intelligence. Based on the company’s core digital health technology platform,’LifeRecord®,’ It is engaged in business fields such as non-face-to-face treatment. In July of last year, it was recognized for its technological prowess and business feasibility by obtaining A grade in the technology evaluation.

‘Lifecode’ provides essential common technologies for each stage of the value chain, such as creation, collection, storage, analysis, value creation, and optimization of personal health data on a cloud basis. The core services provided are 11 types, including integration of health data scattered in various forms and types, data linkage between heterogeneous systems and devices, disease prediction artificial intelligence, knowledge contents, anonymization and encryption, security, and developer tools. Based on these Life Records, the company has built a full lineup of business in the field of digital health, such as digital therapy, non-face-to-face treatment, and medical my data.

Digital therapy is a high-quality software medical device that replaces and complements existing therapy to prevent, manage, and treat medical disorders and diseases. Expectations are growing as they strive to improve regulations to maintain a sustainable health insurance system, such as preparing grounds and inclusion of innovative medical technology evaluation targets.

Lifesemantics’ lineup of digital therapeutic products is’Redpill Sumton’, a respiratory rehabilitation program, and’Red Peel Care’, a prognosis management program for cancer patients. Red Peel Sumton is a solution to monitor, improve symptoms and increase activity levels of respiratory diseases, and Red Peel Care is a program for improving the quality of life through correct prognosis management for cancer patients.

Both products have been confirmed to have therapeutic effects through clinical trials at major domestic university hospitals. A Lifesemantics official said, “As the category for software medical devices was newly established in October of last year, the company will complete the approval and approval from the Ministry of Food and Drug Safety within this year.” Explained.

◆ Increasing demand for non-face-to-face treatment… Leading the industry with the development of digital therapeutics

Amid the recent global pandemic of Corona 19, the demand for non-face-to-face treatment is on the rise, and Life Semantics leads the industry by developing’Dr. I’m doing it.

With’Doctor Call’, a non-face-to-face treatment mediation solution that supports remote monitoring, it secured a foothold to leap to a global platform by obtaining temporary permission for the private first non-face-to-face treatment service through the regulatory sandbox last year.

The Doctor Call service for overseas Koreans is operated in a way that pays service fees between patients and medical institutions, and has built a non-face-to-face treatment network in cooperation with major domestic hospitals such as Bundang Seoul National University Hospital and Seoul Asan Hospital. As temporary non-face-to-face treatment was allowed in Korea through the revision of the government guidelines and the infectious disease prevention method last year, the company plans to expand the Doctor Call service for Koreans.

The industry is also expected to become a popular industry as the demographic structure is gradually aging.

◆U.S. FDA clinical promotion… to become a leading global digital health company

Life Semantics is aspirations to lead the digital healthcare market, which will become a global’new normal’ due to an aging population and deteriorating health insurance finances.

Life Semantics’ medical my data business has a business structure that generates profits through customization after developing digital health services desired by customers, and is divided into B2B and B2C medical my data businesses.

The B2B medical my data business is a business structure that targets key customers to provide core technologies, establishes and manages digital health services, and receives API usage fees. The company is growing its business by signing contracts with major companies in the insurance, healthcare, and cloud fields such as Hanwha Life Insurance, Naver Cloud, and Body Friend. In addition, LH Korea Land and Housing Corporation is pursuing an intelligent home healthcare business for apartment residents, and plans to expand the business area to the construction field in the future.

B2C Medical My Data is a structure that receives service fees through continuous service enhancement by developing new services based on the Life Record platform. Individuals such as’H.AI’, a non-face-to-face sales support tool based on AI for disease prediction,’OHA’, a treatment solution created by cancer experienced and medical professionals, and’Works’, an integrated occupational health management solution based on disease risk prediction. Provides healthcare services anytime, anywhere based on health data.

Seung-Jae Song, CEO of Life Semantics, said, “We will achieve full-scale sales growth through the full-fledged B2B medical my data business, B2C medical my data and non-face-to-face treatment solutions, and commercialization of digital treatments.” We will leap forward as a leading global digital health company by promoting clinical trials in the US FDA.”

On the other hand, Life Semantics’ total number of public offering stocks is 1 million, and the expected offering price per share is 9,000 won to 12,500 won. Demand forecast for institutional investors will be conducted on the 8th to 9th to determine the offering price, and general subscription will be conducted on the 11th to 12th. The listing is scheduled for the end of this month, and the representative organizer is Korea Investment & Securities.

Copyright © Pax Economic TV Unauthorized reproduction and redistribution prohibited